HEG1: Difference between revisions

(One intermediate revision by the same user not shown)

Line 1:

'''HEG1''' is an [[immunostain]] ~~positive~~ in [[malignant mesothelioma]].<ref name=pmid28361969>{{cite journal |authors=Tsuji S, Washimi K, Kageyama T, Yamashita M, Yoshihara M, Matsuura R, Yokose T, Kameda Y, Hayashi H, Morohoshi T, Tsuura Y, Yusa T, Sato T, Togayachi A, Narimatsu H, Nagasaki T, Nakamoto K, Moriwaki Y, Misawa H, Hiroshima K, Miyagi Y, Imai K |title=HEG1 is a novel mucin-like membrane protein that serves as a diagnostic and therapeutic target for malignant mesothelioma |journal=Sci Rep |volume=7 |issue= |pages=45768 |date=March 2017 |pmid=28361969 |doi=10.1038/srep45768 |url=}}</ref>

'''HEG1''' is an [[immunostain]] used in the diagnosis of [[malignant mesothelioma]].<ref name=pmid28361969>{{cite journal |authors=Tsuji S, Washimi K, Kageyama T, Yamashita M, Yoshihara M, Matsuura R, Yokose T, Kameda Y, Hayashi H, Morohoshi T, Tsuura Y, Yusa T, Sato T, Togayachi A, Narimatsu H, Nagasaki T, Nakamoto K, Moriwaki Y, Misawa H, Hiroshima K, Miyagi Y, Imai K |title=HEG1 is a novel mucin-like membrane protein that serves as a diagnostic and therapeutic target for malignant mesothelioma |journal=Sci Rep |volume=7 |issue= |pages=45768 |date=March 2017 |pmid=28361969 |doi=10.1038/srep45768 |url=}}</ref>

==Use==

*Positive in [[malignant mesothelioma]], especially epithelioid type.<ref>{{cite journal |authors=Naso JR, Tsuji S, Churg A |title=HEG1 Is a Highly Specific and Sensitive Marker of Epithelioid Malignant Mesothelioma |journal=Am J Surg Pathol |volume=44 |issue=8 |pages=1143–1148 |date=August 2020 |pmid=32205484 |doi=10.1097/PAS.0000000000001469 |url=}}</ref>

==See also==

*[[Claudin-4]].

*[[BAP1]].

==References==

@@ Line 1: / Line 1: @@
-'''HEG1''' is an [[immunostain]] positive in [[malignant mesothelioma]].<ref name=pmid28361969>{{cite journal |authors=Tsuji S, Washimi K, Kageyama T, Yamashita M, Yoshihara M, Matsuura R, Yokose T, Kameda Y, Hayashi H, Morohoshi T, Tsuura Y, Yusa T, Sato T, Togayachi A, Narimatsu H, Nagasaki T, Nakamoto K, Moriwaki Y, Misawa H, Hiroshima K, Miyagi Y, Imai K |title=HEG1 is a novel mucin-like membrane protein that serves as a diagnostic and therapeutic target for malignant mesothelioma |journal=Sci Rep |volume=7 |issue= |pages=45768 |date=March 2017 |pmid=28361969 |doi=10.1038/srep45768 |url=}}</ref>
+'''HEG1''' is an [[immunostain]] used in the diagnosis of [[malignant mesothelioma]].<ref name=pmid28361969>{{cite journal |authors=Tsuji S, Washimi K, Kageyama T, Yamashita M, Yoshihara M, Matsuura R, Yokose T, Kameda Y, Hayashi H, Morohoshi T, Tsuura Y, Yusa T, Sato T, Togayachi A, Narimatsu H, Nagasaki T, Nakamoto K, Moriwaki Y, Misawa H, Hiroshima K, Miyagi Y, Imai K |title=HEG1 is a novel mucin-like membrane protein that serves as a diagnostic and therapeutic target for malignant mesothelioma |journal=Sci Rep |volume=7 |issue= |pages=45768 |date=March 2017 |pmid=28361969 |doi=10.1038/srep45768 |url=}}</ref>
+==Use==
+*Positive in [[malignant mesothelioma]], especially epithelioid type.<ref>{{cite journal |authors=Naso JR, Tsuji S, Churg A |title=HEG1 Is a Highly Specific and Sensitive Marker of Epithelioid Malignant Mesothelioma |journal=Am J Surg Pathol |volume=44 |issue=8 |pages=1143–1148 |date=August 2020 |pmid=32205484 |doi=10.1097/PAS.0000000000001469 |url=}}</ref>
 ==See also==
 *[[Claudin-4]].
+*[[BAP1]].
 ==References==

HEG1: Difference between revisions

Navigation menu

Search